FDA NDC Directory · JSON-LD · Markdown
NDC 65862-649 · HUMAN PRESCRIPTION DRUG · CAPSULE
| Labeler / Manufacturer | Aurobindo Pharma Limited |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA204572 |
| Dosage form / route | CAPSULE · ORAL |
| Active ingredients | RIVASTIGMINE TARTRATE (3 mg/1) |
| Marketing started | 20160325 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).